Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients - Baccelli, Irène; Stenzinger, Albrecht; Wallwiener, Markus; Sinn, Peter; Schneeweiss, Andreas; Weichert, Wilko (OncoTarget, 2014)